| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |